Clinical Trials Browser

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

Brain Neoplasms, Meningeal Neoplasms, Meningeal Carcinomatosis

Osteosarcoma

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

Stomach Neoplasms

Triple Negative Breast Neoplasms

Carcinoma, Transitional Cell

Urothelial Cancer

Gastrointestinal Stromal Tumors

Leiomyosarcoma, Liposarcoma, Sarcoma, Dermatofibrosarcoma, Histiocytoma, Malignant Fibrous

Carcinoma, Renal Cell, Kidney Diseases, Kidney Neoplasms, Neoplasms

Colorectal Neoplasms

Cancer That is Associated With a Chronic Viral Infection

Uterine Cervical Neoplasms

Neoplasms, Second Primary

Carcinoma, Transitional Cell

Carcinoma, Renal Cell

Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

Non-metastatic Muscle Invasive Bladder Cancer

Carcinoma, Non-Small-Cell Lung

Colorectal Neoplasms

Carcinoma, Renal Cell

Carcinoma, Renal Cell

Neuroendocrine Tumors

Carcinoma, Adenoid Cystic, Disease Progression

Lung Neoplasms

Carcinoma, Renal Cell, Neoplasm Metastasis

Carcinoma, Merkel Cell

Ovarian Neoplasms

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Urologic Neoplasms

Carcinoma, Merkel Cell

Carcinoma, Transitional Cell

Metastatic Solid Tumors

Urinary Bladder Neoplasms

Neoplasm Metastasis

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Diseases, Ovarian Neoplasms

Adenocarcinoma Of Esophagus, Neoplasm Metastasis

Carcinoma, Renal Cell

Carcinoma, Non-Small-Cell Lung

Neoplasm Metastasis, Neoplasms, Recurrence

Mesothelioma, Malignant

Colonic Neoplasms

Carcinoma, Transitional Cell

Leukemia, Myeloid, Acute

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Transitional Cell

Ovarian Neoplasms

Clinical Trials

AVENANCE

Avelumab With Radiotherapy in Patients With Leptomeningeal Disease

A Phase II Trial of Avelumab in Patients With Recurrent or Progressive Osteosarcoma

Cryoablation With Pembrolizumab Or Avelumab In Urothelial Carcinoma

GEN-001 in Combination With Avelumab for Patients With PD-L1 Positive Gastric Cancer

A-Brave

A Combination of Avelumab and Taxane (AVETAX) for Urothelial Cancer

A Study to Learn About the Study Medicine (Called Avelumab) in People With Advanced Urothelial Cancer After Chemotherapy

AXAGIST

Study of DCC-3014 in Combination With Avelumab in Patients With Advanced or Metastatic Sarcomas

JAVELIN Renal 101

SAMCO

LATENT

ALARICE

FOLFIRI + Cetuximab + Avelumab RAS Wild-type CRC

Study of Avelumab-M3814 Combinations

A Study to Learn About the Study Medicine (Avelumab) in Japanese Patients With Urothelial Carcinoma That Has Spread

J-DART2

Avelumab, Utomilumab, Rituximab, Ibrutinib, and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma or Mantle Cell Lymphoma

AMPLIFY-NEOVAC

AURA

Avelumab in First-line NSCLC (JAVELIN Lung 100)

NPC - AXEL Study : Axitinib-Avelumab

AVETRIC

To Examine the Effects of Axitinib Dose Reduction and Interruption for Adverse Event Management Among Patients Receiving Axitinib in for the Treatment of Advanced Renal Cell Carcinoma

Talazoparib and Avelumab in Participants With Metastatic Renal Cell Carcinoma

NET-002

Axitinib and Avelumab in Treating Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma

Combination Treatment (Talazoparib Plus Avelumab) for Stage IV or Recurrent Non-Squamous Non-Small Cell Lung Cancer With STK11 Gene Mutation (A LUNG-MAP Treatment Trial)

AVAIL-T

Cabometyx and Avelumab in Patients With Metastatic Renal Cell Carcinoma (mRCC)

MERKLIN2

Study of Magrolimab (Hu5F9-G4) in Combination With Avelumab in Solid Tumor Participants and Checkpoint-Inhibitor-Naive Ovarian Cancer Participants Who Progress Within 6 Months of Prior Platinum Chemotherapy

JAVELIN Bladder 100

Avelumab in Participants With Merkel Cell Carcinoma (JAVELIN Merkel 200)

SOGUG

Phase I/Ib Multiple Ascending Dose Study in China

OU-SCC-ABC

ARIES

Study of Avelumab With or Without Entinostat in Participants With Advanced Epithelial Ovarian Cancer

Trial of mFOLFOX6 + Trastuzumab + Avelumab in Gastric and Esophageal Adenocarcinomas

Current Treatment Outcomes in Japanese RCC Patients Treated With Avelumab Plus Axitinib as First-line Therapy: Retrospective Study (J-DART)

PAVE-1

Safety of SNK01 in Subjects With Pathologically Confirmed Metastatic and/or Unresectable Cancer Refractory to Conventional Therapy

Stereotactic Body Radiation Therapy and Avelumab Immunotherapy for Treatment of Malignant Mesothelioma

AVANA

INDUCOMAIN

OX40, Venetoclax, Avelumab, Glasdegib, Gemtuzumab Ozogamicin, and Azacitidine in Relapsed or Refractory Acute Myeloid Leukemia

GEN-001 (Live Biotherapeutic Product) and Avelumab Combination Study for Patients With Solid Tumors Who Have Progressed on Anti-PD-(L)1 Therapy

JAVELIN Ovarian 200